• Exchange: AktieTorget
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

CONPB:SS

0.8000 SEK 0.0900 12.68%

As of 12:00:00 ET on 12/23/2014.

Snapshot for Conpharm AB (CONPB)

Open: 0.7500 Day's Range: 0.7500 - 0.8050 Volume: 174,000
Previous Close: 0.7100 52wk Range: 0.4100 - 1.4500 1-Yr Rtn: +8.11%

Stock Chart for CONPB

No chart data available.
  • CONPB:SS 0.8000
  • 1D
  • 1M
  • 1Y
0.7100
Interactive CONPB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CONPB

Current P/E Ratio (ttm) 2.2099
Estimated P/E(-) -
Relative P/E vs. OMX 0.1366
Earnings Per Share (ttm) 0.3620
Est. EPS -
Est. PEG Ratio -
Market Cap (M SEK) 20.59
Shares Outstanding (M) 17.50
30 Day Average Volume 53,347
Price/Book (mrq) 0.7448
Price/Sale (ttm) 2.2375
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CONPB

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for CONPB

Conpharm AB is a pharmaceutical company. The Company develops and markets, through licensees, pharmaceutical products based on substances extracted from the Podyphyllum plant. Conpharm's product line includes Wartec, for the treatment of warts, and Reumacon used to treat rheumatoid arthritis. The Company markets its products worldwide.

Jakob OesterbergChief Executive Officer
More Company Profile & Key Executives for CONPB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil